UK launches AI biosecurity lab with up to £300 million

The UK government is establishing what it calls the world’s first organisation dedicated specifically to AI biosecurity. The new AI Biosecurity Lab, or AIBL, will operate as an independent nonprofit and receive £100 million in public funding.

OpenAI and Anthropic are committing up to another £200 million in support. OpenAI plans to provide £100 million in compute and model credits plus trusted access to relevant frontier models through its Rosalind Biodefense programme. Anthropic will offer up to £100 million in model credits, trusted access and technical support.

The lab’s first priorities are practical: detect emerging biological threats earlier and accelerate the discovery, development and testing of vaccines, treatments and other medical countermeasures. It will work with UK biosecurity agencies, life-sciences companies, universities and international partners.

Google DeepMind will collaborate on research and explore trusted access to Gemini and specialised science models. Basecamp Research will contribute AI-biology models and expertise. The lab will also work with the UK’s medicines regulator on health-emergency preparedness and rules for AI-designed medicines.

The initiative matters because powerful models can help biological research while also lowering barriers to misuse. The UK is trying to build defensive capability alongside model capability, with a dedicated organisation that can turn access to frontier AI into public-health tools.